A trained AI program correctly identified patients with glaucoma 88% to 90% of the time, compared with 79% to 81% for human ...

Glaucoma therapies have come a long way, but pain points still remain, according to a speaker at the American Academy of ...

Innovations in selective laser trabeculoplasty and laser cyclophotocoagulation focus on procedural efficiency, patient ...

A licensing agreement between SERI and Eyexora Global has launched Y.ora Vision, a new ophthalmic medical device company.

A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, ...

High uric acid levels, or hyperuricemia, are now linked to serious eye problems beyond gout and kidney stones. Research ...

Glaucoma is a leading cause of blindness among adults. The disease involves an increase in pressure in the eye, which distorts the shape of the eyeball, damaging the lens of the eye, and resulting in ...

While artificial intelligence (AI)-powered screening has been validated for diabetic retinopathy, applying the technology to glaucoma has proved more challenging because glaucoma is not one disease. A ...

Another study points to the likelihood that primary open-angle glaucoma (POAG) is an autoimmune phenomenon, with Korean researchers reporting that people with rheumatoid arthritis (RA) are also at ...